Breaking
Friday, June 19, 2026

Licensing

🇺🇸 FDA Page 3

FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page

Unlock global pharma market opportunities. Get expert insights on drug licensing deals, IP strategies, and M&A trends for strategic BD.

Showing 25–36 of 59 articles

High impact AnalysisJun 2, 2026

Vyome Holdings Q1 2026: FDA Filings and Financial Strength Signal Strategic Momentum

FDA · 10 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Rallybio, Avenzo agree oncology reverse merger backed by $215 million financing

oncology · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

OhioHealth and Fairfield Medical Center Terminate Merger Plans

8 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Servier Acquires Edgewise Therapeutics' Muscular Dystrophy Assets in Potential $2.7 Billion Deal

muscular dystrophy · 13 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

White House Taps Amazon, GoodRx to Expand TrumpRx Generic Drug Access

FDA · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

BMS-Hengrui $15B Deal: Strategic Implications for Pharma Executives

FDA · 10 min

Dr. Sarah Mitchell
High impact NewsJun 2, 2026

Longeveron Stockholder Letter Outlines 2026 Strategy and Partnership Focus

FDA · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

TrumpRx Expands Generic Drug Offerings: Implications for Pharma BD and Investors

FDA · 10 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Eli Lilly's Strategic Vaccine Acquisitions: A New Era in Infectious Disease

FDA · vaccine · 6 min

Dr. Sarah Mitchell
High impact AnalysisJun 2, 2026

Eli Lilly Acquires Engage Bio to Advance Non-Viral Genetic Medicines

FDA · genetic medicines · 7 min

Dr. Sarah Mitchell
High impact AnalysisJun 1, 2026

Merck's ADC Success: Insights from Global Trial Results

FDA · oncology · 8 min

Dr. Sarah Mitchell
High impact AnalysisJun 1, 2026

Niowave's $75M Radiopharmaceutical Plant: Industry Implications

FDA · 8 min

Dr. Sarah Mitchell